PET/CT stands for Positron Emission Tomography (PET) used in combination with Computerized Tomography (CT). It is an advanced diagnostic study that produces images of the body’s cellular functions. Instead of detecting changes in the physical size or structure of internal organs, as other imaging technologies (X-Ray, CT, MRI), the PET/CT scan assesses and measures changes in metabolic function. Since these functional changes may take place before physical changes occur, PET/CT can often provide information that enables your physician to make an earlier diagnosis of diseases or abnormalities.
PET/CT scans use a glucose tracer. These tracers journey through the body and collect in cells with increased metabolism. All cells use glucose, however, diseased cells, such as cancerous cells, use it faster than healthy cells. The PET/CT scanner produces images of the diseased tissues that have absorbed the glucose tracer. The CT component of the scan better visualizes and localizes organs to determine cancerous cells.
PET/CT is a safe and accepted method for imaging many forms of cancer, including lung, colorectal, melanoma, ovarian, lymphoma, and recurrent brain cancer. It can also be used to assess heart disease and neurological disorders such as Alzheimer’s disease and some forms of epilepsy.